UK markets open in 2 hours 40 minutes

FitLife Brands, Inc. (FTLF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
28.00-0.38 (-1.34%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close28.38
Open28.25
Bid0.00 x 0
Ask0.00 x 0
Day's range28.00 - 28.29
52-week range15.05 - 30.80
Volume3,261
Avg. volume6,448
Market cap128.751M
Beta (5Y monthly)0.78
PE ratio (TTM)25.93
EPS (TTM)1.08
Earnings date12 Aug 2024 - 16 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    FitLife Brands Announces First Quarter 2024 Results

    Omaha, May 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2024. Highlights for the first quarter ended March 31, 2024 include: Total revenue was $16.5 million, an increase of 54% compared to the first quarter of 2023. Online sales were $10.8 million, representing 65% of total revenue and an

  • GlobeNewswire

    FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update

    OMAHA, NE, May 08, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the Sidoti Virtual Investor Conference on Wednesday and Thursday, May 8-9, 2024. The Company’s presentation will begin at 1:45pm EDT on May 9, 2024, and can be accessed live at the following link: https://sidoti.zoom.us/webinar/register/WN_VDHnrzFZSqGQgICgi

  • Insider Monkey

    MusclePharm Acquisition Helped FitLife Brands (FTLF)

    Alluvial Capital Management, an investment advisory firm, released its first-quarter 2024 investor letter. A copy of the same can be downloaded here. Alluvial Fund rose 6.3% in Q1, outperforming comparable indexes which were up between 4.3% and 5.2%. The overall increase was comprehensive, as multiple assets in the portfolio made significant contributions. In addition, you […]